News for ldri
Bruxelles Woluwe
September 27, 2017
21 September 2017, New PhD at the LDRI, Dario Carradori
Novel nanoparticle-based drug delivery system for neural stem cell targeting and differentiation
Related publications
Carradori et al. The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation. Biomaterials. 2017;123:77-91....
Click to know more 
July 10, 2017
Antibiotiques et mucoviscidose : une bonne idée ?
Les chercheurs de l’UCL ont découvert que les macrolides, antibiotiques fréquemment prescrits aux personnes atteintes de mucoviscidose, favorisaient la résistance de la bactérie Pseudomonas aeruginosa. Une découverte qui inquiète.
Pseudomonas aeruginosa est une bactérie très commune, que l’on...
Click to know more 
June 07, 2017
PhD Day at the LDRI, 23 May 2017
Deux prix ont été remis lors de ce PhD Day !
- prix de la communication orale : Marie-Julie Guichard "Development of a PEGylated version of dornase alfa for the treatment of cystic fibrosis"
- Prix du poster : Léopold Thabault "Towards the validation of a new anticancer strategy: Targeting...
Click to know more 
June 07, 2017
6 June 2017, New PhD at the LDRI, Julien Masquelier
"Targeted and untargeted lipidomics studies: towards a better understanding of the role of lipids in inflammation"
Related publications:
° Masquelier J, Muccioli GG. Development and validation of a specific and sensitive HPLC-ESI-MS method for quantification of lysophosphatidylinositols...
Click to know more 
May 22, 2017
The last paper of the TFAR-FACM group published in the...
Call for caution: Prolonged treatment with macrolide antibiotics in cystic fibrosis patients selects for resistance in Pseudomonas aeruginosa.
The last paper of the FACM/TFAR group published in the European Respiratory Journal (http://ow.ly/B5vC308qfjl) questions the prolonged use of oral...
Click to know more